Evoke Pharma, Inc. (EVOK)
11.00
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Evoke Pharma Total Assets (Quarterly) : 15.65M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 15.65M |
| June 30, 2025 | 16.06M |
| March 31, 2025 | 16.38M |
| December 31, 2024 | 17.52M |
| September 30, 2024 | 14.15M |
| June 30, 2024 | 12.14M |
| March 31, 2024 | 12.45M |
| December 31, 2023 | 7.068M |
| September 30, 2023 | 7.853M |
| June 30, 2023 | 8.980M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 11.85M |
| September 30, 2022 | 13.41M |
| June 30, 2022 | 14.40M |
| March 31, 2022 | 9.026M |
| December 31, 2021 | 10.57M |
| September 30, 2021 | 11.65M |
| June 30, 2021 | 17.56M |
| March 31, 2021 | 19.30M |
| December 31, 2020 | 9.434M |
| September 30, 2020 | 6.751M |
| June 30, 2020 | 8.267M |
| March 31, 2020 | 4.638M |
| December 31, 2019 | 6.396M |
| September 30, 2019 | 7.327M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.631M |
| March 31, 2019 | 4.363M |
| December 31, 2018 | 5.660M |
| September 30, 2018 | 7.018M |
| June 30, 2018 | 6.626M |
| March 31, 2018 | 5.585M |
| December 31, 2017 | 7.942M |
| September 30, 2017 | 10.76M |
| June 30, 2017 | 13.16M |
| March 31, 2017 | 14.84M |
| December 31, 2016 | 9.294M |
| September 30, 2016 | 10.81M |
| June 30, 2016 | 4.636M |
| March 31, 2016 | 6.872M |
| December 31, 2015 | 9.532M |
| September 30, 2015 | 11.68M |
| June 30, 2015 | 10.61M |
| March 31, 2015 | 12.62M |
| December 31, 2014 | 15.30M |
| September 30, 2014 | 13.39M |
| June 30, 2014 | 17.02M |
| March 31, 2014 | 22.57M |
| December 31, 2013 | 24.99M |
| September 30, 2013 | 23.74M |
| June 30, 2013 | 1.793M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.29M |
| Shareholders Equity (Quarterly) | 3.362M |